Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

ertugliflozin-SITagliptin

ertugliflozin-SITagliptin
  • Non-formulary
  • Therapeutic Interchange
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Steglujan TABLET, ORAL 5 mg-100 mg, 15 mg-100 mg    
Comments:
 
Steglujan medication guide
Ordered Formulation Therapeutic Interchange

ertugliflozin-SITagliptin (Steglujan)

  • 5 mg-100 mg oral tablet                                                                      
  • 15 mg-100 mg oral tablet

ertugliflozin (Steglatro) and SITagliptin (Januvia)

  • ONE 5 mg ertugliflozin oral tabletPLUS ONE SITagliptin 100 mg oral tablet
  • ONE 15 mg ertugliflozin oral tabletPLUS ONE SITagliptin 100 mg oral tablet
Reviewed: 18 Dec 18 (Steglujan)
 
Last updated: Dec. 19, 2018






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved